Demo PE Holdco L.L.C.

in progress

CAM-0001/2026 · Private Banking & Wealth Management · Demand Loan USD 100.0 MM · Current stage: 2. CAM Preparation

OriginationCompleted
2PreparationIn progress
BusinessLocked
Credit AdminLocked
RiskLocked
CommitteeLocked
RegulatoryLocked
Docs & CPsLocked
DisbursementLocked
MonitoringLocked

Stage 2 of 10 · Owner: Business Unit analyst (Preparer)

CAM Preparation

Run AI extraction over the document pack, verify financial spreads and ratios, edit AI-drafted narrative, build the term sheet and propose a risk rating.

Run AI extraction
Verify spreads & ratios
Edit CAM drafts
Build term sheet
Propose risk rating
Submit draft CAM

Gate: Draft CAM submitted

3 requirement(s) outstanding.

To complete this stage:

CAM section "nature of request" is empty
CAM section "recommendation" is empty
Propose a risk rating

AI document analysis

4 document(s), ~70 pages · 0 not yet extracted. Extraction reads each document, captures every figure with its page reference, fills the financial spreads, parties and collateral, and raises red flags.

Only new / changed

Metered: every run is logged with pages, tokens and cost (see AI usage). Re-running a document replaces its previous extraction; verified manual edits to spreads from other sources are kept.

Medicare FS 30.09.2025 English.pdfextracted

367.1 KB · 9 pages · uploaded 05 Sept 2026 19:49 by Person 2

Medicare Group Q.P.S.C. condensed interim financial statements for the nine-month period ended 30 September 2025. The statements are expressly marked unaudited and are therefore treated as management accounts. Comparative figures are provided for the nine-month period ended 30 September 2024 and, for the statement of financial position, 31 December 2024 audited balances. No auditor or audit opinion is presented. The statements appear internally consistent: total assets equal total equity and liabilities, and cash flow closing cash reconciles to the statement of financial position. The document states that interim results are not necessarily indicative of the full-year result. The 2025 nine-month period shows revenue of QAR 376.1m, profit of QAR 62.1m, operating cash flow of QAR 68.9m and total debt components of QAR 159.8m. Credit should consider imposing an audited financial statements condition because the current spread is unaudited and does not include an audit opinion.

Signed Medicare Group FS 31 March 2025 English.pdfextracted

321.8 KB · 8 pages · uploaded 05 Sept 2026 19:49 by Person 2

Medicare Group Q.P.S.C. interim condensed financial statements for the three-month period ended 31 March 2025. The current-period statements are explicitly marked unaudited and therefore treated as management accounts. Comparative balance sheet figures at 31 December 2024 are marked audited, while comparative income statement and cash-flow figures for the three-month period ended 31 March 2024 are marked unaudited. No external auditor or audit opinion is identified in the provided document. The statements are stated in Qatari Riyals (QR) and were approved for issue on 21 April 2025.

Medicare Group FS 31 Dec 2025_E_signed.pdfextracted

1.3 MB · 35 pages · uploaded 05 Sept 2026 19:49 by Person 2

Audited financial statements of Medicare Group Q.P.S.C. for the year ended 31 December 2025, with comparative 2024 figures. Revenue declined 4.0% year on year to QR 502.6 million, while profit for the year increased 26.6% to QR 76.0 million, partly reflecting the absence of the 2024 discontinued-operations loss. Total assets decreased 1.1% to QR 1.384 billion, total debt decreased 19.0% to QR 150.0 million, and total equity increased 2.2% to QR 1.031 billion. Net operating cash flow was QR 95.2 million against debt repayments of QR 35.3 million. The statements received an unqualified opinion from KPMG. Credit-relevant matters include significant trade receivables over 120 days, an allowance for receivables of QR 75.8 million, related-party balances and transactions, a property valuation based on a 31 December 2023 appraisal, capital commitments of QR 28.8 million, and loan covenants reported as complied with at year-end.

Medicare Group QPSC_30 June 2025_Final English_signed.pdfextracted

1.1 MB · 18 pages · uploaded 05 Sept 2026 19:49 by Person 2

Medicare Group Q.P.S.C. condensed interim financial statements as at and for the six-month period ended 30 June 2025, prepared under IAS 34 and presented in Qatari Riyals. The statements were reviewed, not audited, by KPMG, Qatar Branch. KPMG issued an unmodified review conclusion stating that nothing came to its attention indicating non-compliance with IAS 34. The document includes comparative six-month 2024 figures and audited 31 December 2024 balance-sheet comparatives. Key credit matters include borrowings of QR 168.2 million, capital commitments of QR 40.8 million, related-party balances and transactions, and property valuations based on a 31 December 2023 appraisal.

Upload documents

Drop files here or click to browse

Up to 60 MB per file · multiple files allowed

Document category

Description(optional)

Financial spreads — Borrower (Demo PE Holdco L.L.C.)

QAR 000s · management / audited · 175 AI-extracted value(s) awaiting verification

9 periods3M 2024 → FY2025 · oldest to newest· Ctrl + scroll to zoom · arrows, Home / End and Page keys to move

Line item	3M 2024	6M 2024	9M 2024	FY2024	3M 2025	2025–Jun	6M 2025	9M 2025	FY2025
Income statement
Revenue	p.3	p.6	p.3	p.8	p.3	—	p.6	p.3	p.8
Cost of sales	p.3	p.6	p.3	p.8	p.3	—	p.6	p.3	p.8
Gross profit	p.3	p.6	p.3	p.8	p.3	—	p.6	p.3	p.8
Operating expenses	—	p.6	p.3	p.8	—	—	p.6	p.3	p.8
Depreciation & amortisation	p.3	p.6	p.3	p.8	p.3	—	p.6	p.3	p.8
Net profit / (loss)	p.3	p.6	p.3	p.8	p.3	—	p.6	p.3	p.8
Balance sheet
Total assets	—	—	—	p.7	p.2	p.5	—	p.2	p.7
Current assets	—	—	—	p.7	p.2	p.5	—	p.2	p.7
Cash & bank balances	—	—	—	p.7	p.2	p.5	—	p.2	p.7
Receivables	—	—	—	p.7	p.2	p.5	—	p.2	p.7
Inventory	—	—	—	p.7	p.2	p.5	—	p.2	p.7
Investments	—	—	—	p.7	p.2	p.5	—	—	p.7
Total liabilities	—	—	—	p.7	p.2	p.5	—	p.2	p.7
Current liabilities	—	—	—	p.7	p.2	p.5	—	p.2	p.7
Total debt	—	—	—	p.7	p.2	p.11	—	—	p.7
Short-term debt	—	—	—	p.7	p.2	p.11	—	p.2	p.7
Long-term debt	—	—	—	p.7	p.2	p.11	—	p.2	p.7
Net worth	—	—	—	p.7	p.2	p.5	—	p.2	p.7
Related-party balances	—	—	—	—	—	p.15	—	—	—
Cash flow
Operating cash flow	p.4	p.8	p.4	p.10	p.4	—	p.8	p.4	p.10
Capital expenditure	p.4	p.8	p.4	p.10	p.4	—	p.8	p.4	p.10
Dividends paid	p.4	p.8	p.4	p.10	p.4	—	p.8	p.4	p.10
Debt service	p.4	—	—	—	p.4	—	—	—	—
Revenue breakdown
Revenue from patient services	—	p.12	—	p.27	—	—	p.12	—	p.27
Operating income	p.3	—	—	—	p.3	—	—	—	—
Sale of medications	—	p.12	—	p.27	—	—	p.12	—	p.27

4 cells hold a different value for the same line and period in more than one source — or under two labels for the same period, which the grid now shows as one column. The first extracted value is shown and is the one the ratios use — hover the red marker to see each figure and where it came from, then correct the cell and save.

The source document does not say how long the period As at 30 Jun 2025 is, so 12 months has been assumed — and this spread also holds a shorter column for the same year. Interim statements report cumulatively (“nine months ended 30 September”), so a comparative column inside one is a three- or six-month figure, not a year. Open the source and read the column heading, then set the length here: .

Columns run oldest to newest; the line item column and the period headers stay locked while you scroll. Under each period the header shows how many months it covers — 9M as printed on the statement, 12M? where the length was assumed because the heading does not say, and ? where nothing states it; hover a header for the document’s own wording. That marker is also the control: click it to set the months (and the period end) for the whole column when the heading says something the extraction missed. Amber cells are AI-extracted and unverified — click the page reference under a figure to open the source, then edit or “Mark all verified”. Values in QAR 000s, negatives in (brackets). Ctrl + scroll to zoom, and drag the right edge of the line item column to widen it.

Financial spreads — Guarantor (Demo Investment Bank Q.P.S.C.)

No spread yet — run AI extraction on the financial statements or add rows manually.

Ratios vs bank thresholds

Every ratio is computed from one reporting period of one type — benchmarks are configurable in Settings → Thresholds (placeholders until the bank's credit policy is loaded).

Metric	Value	Assessment	Note
borrowerDebt service coverage (DSCR) (FY2025)	—	na	Not computed — EBITDA and debt service not reported for FY2025; figures from other periods are not mixed in
borrowerInterest coverage (EBITDA / interest) (FY2025)	—	na	Not computed — EBITDA and finance cost not reported for FY2025; figures from other periods are not mixed in
borrowerLeverage (total liabilities / tangible net worth) (FY2025)	0.34x	good	Uses net worth (tangible net worth not extracted)
borrowerCurrent ratio (FY2025)	1.34x	acceptable
borrowerRevenue trend (latest year) (FY2025)	-4.0%	acceptable	Change on FY2024
borrowerProfitability (net margin) (FY2025)	15.1%	good
borrowerLTV on pledged securities / fund units (term sheet)	50%	good
borrowerSecurity coverage (collateral / exposure) (term sheet)	200%	good

Red flags · 34 open

Raised by AI extraction and by rule checks (missing documents, stale valuations, audit opinions, trends). Resolving a flag records who cleared it and why.

Missing: QCB / Credit Bureau reportshighrule
No document in category "Bureau reports" has been uploaded.
Missing: KYC & constitutional documentshighrule
No document in category "KYC / constitutional" has been uploaded.
Going-concern languagehighrule
Management assessed the Company's ability to continue as a going concern and was satisfied that it has the resources to continue in business for the foreseeable future. Management was not aware of any material uncertainties that may cast significant doubt on the Company's ability to continue as a going concern.
Medicare Group FS 31 Dec 2025_E_signed.pdf · p.11
Unaudited management accountshighMgmt accounts
The document is a condensed interim financial statement package marked unaudited. No auditor or audit opinion is provided. Consider imposing a condition requiring audited annual financial statements and the auditor's report.
Medicare FS 30.09.2025 English.pdf · p.1
Current-period accounts are unauditedhighMgmt accounts
The 31 March 2025 interim financial statements are explicitly marked unaudited and no auditor or audit opinion is included. Consider imposing an audit condition requiring delivery of audited annual financial statements, and clarify whether interim figures are subject to limited review.
Signed Medicare Group FS 31 March 2025 English.pdf · p.2
Significant aged trade receivableshighAudited FS
Of gross trade receivables of QR 166,470,734, QR 118,951,636 was over 120 days past due. The expected credit loss allowance was QR 75,552,730 for this ageing bucket and QR 75,776,442 in total.
Medicare Group FS 31 Dec 2025_E_signed.pdf · p.31
No statutory audit for current-period financialshighMgmt accounts
The 30 June 2025 financial statements are condensed interim statements reviewed by KPMG rather than audited. The review report expressly states that no audit opinion is expressed and that a review provides substantially less assurance than an audit. Credit documentation should consider imposing a condition requiring submission of audited annual financial statements, with timing and auditor requirements specified.
Medicare Group QPSC_30 June 2025_Final English_signed.pdf · p.3
Cash presentation requires attentionlowMgmt accounts
Statement of financial position cash and cash equivalents of QAR 65662547 includes QAR 47000000 of short-term deposits with original maturity over 90 days. The cash flow statement presents period-end cash and cash equivalents of QAR 18662547 after excluding those deposits. The figures reconcile when the deposits are excluded; liquidity analysis should distinguish unrestricted cash from longer-maturity deposits.
Medicare FS 30.09.2025 English.pdf · p.6
Cash-flow and financial-position cash figures differ by deposit classificationlowMgmt accounts
Cash and cash equivalents are 116771572 QR in the statement of financial position but 13771572 QR in the cash-flow statement because 103000000 QR of short-term deposits with maturity over 90 days is excluded from cash-flow cash equivalents. The difference is explained in Note 6 and is internally consistent.
Signed Medicare Group FS 31 March 2025 English.pdf · p.6
No related-party balances identifiedlowMgmt accounts
No related-party balances are disclosed in the provided eight-page document. This is not evidence that no such balances exist; the interim statements state that they do not include all annual disclosures.
Signed Medicare Group FS 31 March 2025 English.pdf · p.5
Comparative-period scope differs by statementlowMgmt accounts
The balance sheet compares 31 March 2025 with 31 December 2024, while the income statement and cash-flow statement compare three-month periods ended 31 March 2025 and 31 March 2024. The periods have been kept as separate columns.
Signed Medicare Group FS 31 March 2025 English.pdf · p.2
Unqualified audit opinionlowAudited FS
KPMG expressed an unqualified opinion stating that the financial statements present fairly, in all material respects, the Company's financial position, performance and cash flows.
Medicare Group FS 31 Dec 2025_E_signed.pdf · p.3
Going concern assessmentlowAudited FS
Management stated that it had sufficient resources to continue as a going concern and was not aware of material uncertainties casting significant doubt on going concern.
Medicare Group FS 31 Dec 2025_E_signed.pdf · p.11
Proposed dividend not recognised as liabilitylowAudited FS
A QR 61,917,020 dividend for FY2025 was proposed after the reporting date and was not recognised in the financial statements.
Medicare Group FS 31 Dec 2025_E_signed.pdf · p.26
Discontinued operations in comparative periodlowAudited FS
FY2024 includes a QR 34,095,908 loss from discontinued operations following cessation of the Wakra Clinic operation on 30 April 2024, which affects year-on-year comparability of reported profit.
Medicare Group FS 31 Dec 2025_E_signed.pdf · p.34
Comparative reclassificationlowAudited FS
Certain FY2024 comparative balances were reclassified, including a QR 13,582,330 deduction for employees' end-of-service benefits paid in advance from accounts receivable and prepayments and liabilities.
Medicare Group FS 31 Dec 2025_E_signed.pdf · p.35
Cash-flow and balance-sheet cash figures differ by short-term depositslowMgmt accounts
The balance-sheet cash and cash equivalents figure of QR 66,220,526 exceeds the cash-flow ending balance of QR 9,220,526 because QR 57,000,000 of deposits with original maturity exceeding 90 days is excluded for cash-flow classification. The difference is explicitly reconciled in Note 7.
Medicare Group QPSC_30 June 2025_Final English_signed.pdf · p.10
Comparative profit is affected by discontinued operationslowMgmt accounts
The 6M 2024 comparative profit of QR 11,283,805 includes a QR 34,095,908 loss from discontinued Wakra Clinic operations, whereas 6M 2025 has no discontinued-operation loss. This explains the significant year-on-year increase in reported profit and should be considered when assessing recurring earnings.
Medicare Group QPSC_30 June 2025_Final English_signed.pdf · p.18
Missing: Bank statementsmediumrule
No document in category "Bank statements" has been uploaded.
Missing: Collateral documentationmediumrule
No document in category "Collateral" has been uploaded.
Interim information is incomplete for annual credit assessmentmediumMgmt accounts
The basis of preparation states that the interim statements do not include all information and disclosures required in the annual financial statements and that nine-month results are not necessarily indicative of the full-year result.
Medicare FS 30.09.2025 English.pdf · p.5
Significant expected credit loss provisionmediumMgmt accounts
Gross accounts receivable and prepayments of QAR 206956902 are reduced by an expected credit loss provision of QAR 76435439, leaving net accounts receivable and prepayments of QAR 130521463.
Medicare FS 30.09.2025 English.pdf · p.6
Discontinued operation and impairmentmediumMgmt accounts
Wakra Clinic was discontinued from 30 April 2024. The comparative period includes a discontinued-operations loss of QAR 34095908, including impairment of non-financial assets of QAR 36242212.
Medicare FS 30.09.2025 English.pdf · p.8
Management accounts classificationmediumMgmt accounts
The document is an interim condensed financial statement package, not audited financial statements. It should be treated as management accounts for current-period credit analysis.
Signed Medicare Group FS 31 March 2025 English.pdf · p.2
Discontinued operationsmediumMgmt accounts
Wakra Clinic ceased operations on 30 April 2024 and was classified as discontinued operations. The 3M 2024 comparative includes a loss of 2770423 QR from discontinued operations; 3M 2025 reports no such loss.
Signed Medicare Group FS 31 March 2025 English.pdf · p.7
Large expected credit loss provisionmediumMgmt accounts
Gross accounts receivable and prepayments of 201636216 QR are reduced by an expected credit loss provision of 76435439 QR, leaving net balances of 125200777 QR. The provision represents a material portion of gross balances and should be assessed for recoverability and ageing.
Signed Medicare Group FS 31 March 2025 English.pdf · p.6
Revenue recognition identified as key audit mattermediumAudited FS
Revenue of QR 502,601,326 was identified as a key audit matter because of the volume and significance of transactions, complex IT systems, third-party payer arrangements and risk of management override of controls.
Medicare Group FS 31 Dec 2025_E_signed.pdf · p.4
Related-party balances and transactionsmediumAudited FS
The company disclosed related-party balances including receivables of QR 3,125,808, trade payables of QR 4,357,503 and bank balances of QR 1,611,556, together with insurance expenses of QR 13,626,746.
Medicare Group FS 31 Dec 2025_E_signed.pdf · p.30
Property valuation older than 12 monthsmediumAudited FS
Land and buildings with a Level 3 fair value of QR 737,924,895 were supported by an independent appraisal dated 31 December 2023, rather than a valuation at the 31 December 2025 reporting date.
Medicare Group FS 31 Dec 2025_E_signed.pdf · p.22
Debt covenant exposuremediumAudited FS
The outstanding QR 150,000,008 bank facility is subject to net debt/EBITDA and debt-service-coverage covenants. The company reported compliance at year-end and expected compliance for at least 12 months after the reporting date.
Medicare Group FS 31 Dec 2025_E_signed.pdf · p.26
Capital commitmentsmediumAudited FS
Capital commitments amounted to QR 28,797,819 at 31 December 2025, primarily relating to building development and medical equipment.
Medicare Group FS 31 Dec 2025_E_signed.pdf · p.29
Property valuation is older than 12 monthsmediumMgmt accounts
The Level 3 valuation of land and buildings was based on an appraisal performed on 31 December 2023, more than 12 months before 30 June 2025. The company states that it believes no significant change in fair value has occurred, but no current independent valuation is provided.
Medicare Group QPSC_30 June 2025_Final English_signed.pdf · p.17
Significant capital commitmentsmediumMgmt accounts
Capital commitments amounted to QR 40,840,908 at 30 June 2025, primarily for building development and medical equipment, in addition to outstanding borrowings of QR 168,187,178.
Medicare Group QPSC_30 June 2025_Final English_signed.pdf · p.14
Related-party balances and transactionsmediumMgmt accounts
The company reports related-party bank facilities, trade payables, receivables and bank balances. Related-party transactions also include insurance expenses of QR 7,357,496 and finance costs of QR 140,606 for the six-month period ended 30 June 2025.
Medicare Group QPSC_30 June 2025_Final English_signed.pdf · p.14

Nature of request & term sheet

Structured facility terms. Narrative term-sheet items (disbursement, repayment, security, covenants) are drafted as CAM sections below.

Facility type

Facility amountin USD 000s

USD 000s

= USD 100.0 MM · ≈ QAR 365,000K at parity 3.65

Tenor (years)

Availability / drawdown period (years)

Interest index

Spread (% p.a.)

Max all-in rate (%)(manual)

Formula gives 2.82% ·

Commitment fee (% p.a.)

Management fee (% p.a.)

Prepayment fee (%)

Refinance carve-out (USD 000s)

Related exposure (QAR 000s)(group / connected)

Added to the Facility Limit Summary grand total, so it drives the large-exposure flag and the approval level.

LTV cap (%)(linked)

Security coverage (%)(linked)

LTV = 1 ÷ security coverage. Editing either recalculates the other; the field you edit last wins.

LTV top-up trigger (%)

LTV liquidation trigger (%)

Governing law

Limit expiry

Regulatory prerequisites (block disbursement until cleared in Stage 7)

QCB approval for FX lending

Facility Limit Summary

Figures in QAR 000s (USD converted at parity 3.65). Capital base QAR 8,000,000K → limit 4.56% of capital base.

#	Proposed	Change	Collateral (QAR 000s)
1		365,000
SUB-TOTAL	365,000	Large exposure: N · Related director: N	730,000
RELATED EXPOSURE	NIL	Edit in the term sheet (Related exposure)
GRAND TOTAL	365,000

Collateral (QAR 000s) = proposed × security coverage (200%). Overriding a row keeps that figure until you clear it back to auto; the saved facility row holds only the free-text collateral note.

Borrower, guarantor & collateral

AI extraction fills these from KYC, guarantor and collateral documents — verify and complete.

Borrower

Legal name

Risk rating (RR)

Domicile

Industry / sector code

Company type

Regulator / licensing authority

Licence type

Licence / CR number

Incorporation date

Account number

Group / ownership structure

Current bankers & transfer undertaking

Guarantor

Name

Incorporation year

Regulator

Business description & strategy

Link to borrower (options, trusts…)

Collateral (values in 000s)

No collateral recorded.

Collateral values feed the security-coverage and LTV ratios and the disbursement coverage check.

CAM narrative · 0/23 written · 0 approved

AI-drafted text stays marked until a human edits or approves it. Every draft cites its source document and page.